Otępienie z ciałami lewy’ego
Etiologia i przyczyny

Otępienie z ciałami Lewy’ego (DLB) stanowi 5-10% wszystkich przypadków otępienia i jest drugą co do częstości przyczyną po chorobie Alzheimera. Patologicznie charakteryzuje się obecnością wewnątrzkomórkowych eozynofilowych inkluzji – ciał Lewy’ego, zbudowanych głównie z nieprawidłowo sfałdowanego białka alfa-synukleiny, lokalizujących się w korze mózgowej (szczególnie w płatach czołowych i skroniowych), pniu mózgu oraz innych strukturach. Patogeneza DLB obejmuje dysfunkcję mitochondriów, stres oksydacyjny oraz zaburzenia funkcji lizosomów, co prowadzi do agregacji alfa-synukleiny, uszkodzenia neuronów dopaminergicznych i cholinergicznych oraz ostatecznej neurodegeneracji. Klinicznie DLB manifestuje się wczesnym pogorszeniem funkcji poznawczych, zaburzeniami ruchowymi podobnymi do choroby Parkinsona, halucynacjami wzrokowymi oraz zaburzeniami zachowania w fazie snu REM. Średni wiek zachorowania wynosi około 75 lat, a mężczyźni chorują częściej niż kobiety. Współwystępowanie patologii charakterystycznych dla choroby Alzheimera (blaszki amyloidowe, splątki neurofibrylarne) jest częste, zwłaszcza u osób powyżej 80. roku życia, co komplikuje obraz kliniczny i przyspiesza progresję choroby.

Etiologia otępienia z ciałami Lewy’ego

Otępienie z ciałami Lewy’ego (Dementia with Lewy bodies, DLB) jest jedną z najczęstszych form otępienia, uważaną za drugą co do częstości występowania po chorobie Alzheimera, stanowiącą około 5-10% wszystkich przypadków otępienia. DLB cechuje się postępującym pogorszeniem funkcji poznawczych, które wpływa na codzienne funkcjonowanie pacjenta12. Precyzyjna przyczyna tej choroby nie jest w pełni poznana, ale naukowcy stale poszerzają wiedzę na temat jej biologii i podłoża genetycznego3.

Patofizjologia ciał Lewy’ego

Głównym patologicznym wyznacznikiem otępienia z ciałami Lewy’ego jest obecność wewnątrzkomórkowych eozynofilowych inkluzji zwanych ciałami Lewy’ego w komórkach nerwowych mózgu4. Ciała Lewy’ego składają się głównie z nieprawidłowo uformowanej (źle sfałdowanej) postaci białka alfa-synukleiny, które gromadzi się wewnątrz neuronów56. Złogi te uszkadzają komórki nerwowe, ostatecznie prowadząc do ich śmierci7.

Ciała Lewy’ego występują typowo w głębokich warstwach kory mózgowej na całej powierzchni mózgu, szczególnie w przednich płatach czołowych i skroniowych, zakręcie obręczy oraz wyspie8. Występują również w pniu mózgu, podwzgórzu, zwojach podstawy, dolnych oliwkach, tworzeniu siateczkowatym pnia mózgu i jądrach zębatych móżdżku9.

Zaburzenia neuroprzekaźników

Naukowcy odkryli, że nagromadzenie ciał Lewy’ego wiąże się z utratą określonych neuronów w mózgu, które produkują ważne neuroprzekaźniki10. W otępieniu z ciałami Lewy’ego występują zaburzenia dwóch kluczowych neuroprzekaźników:

  • Acetylocholiny – która odgrywa istotną rolę w procesach uczenia się i pamięci1112
  • Dopaminy – która wpływa na zdolności ruchowe, myślenie, motywację, sen i nastrój1314

Niedobór dopaminy prowadzi do problemów z poruszaniem się, podobnych do tych obserwowanych w chorobie Parkinsona, podczas gdy niedobór acetylocholiny wpływa na funkcje poznawcze, powodując objawy otępienia1516.

Związek z innymi chorobami neurodegeneracyjnymi

Otępienie z ciałami Lewy’ego wykazuje znaczące powiązania z chorobą Parkinsona i chorobą Alzheimera17. U wielu pacjentów z DLB występuje nie tylko nagromadzenie ciał Lewy’ego, ale również zmiany patologiczne charakterystyczne dla choroby Alzheimera, takie jak blaszki amyloidowe i splątki neurofibrylarne1819.

Otępienie z ciałami Lewy’ego i otępienie w chorobie Parkinsona (Parkinson’s disease dementia, PDD) są często traktowane jako część spektrum tej samej choroby2021. Główna różnica diagnostyczna polega na kolejności pojawiania się objawów:

  • W otępieniu z ciałami Lewy’ego – zaburzenia poznawcze pojawiają się wcześnie, przed lub w ciągu roku od wystąpienia objawów ruchowych22
  • W otępieniu w chorobie Parkinsona – otępienie rozwija się po wielu latach trwania objawów ruchowych23

Obie choroby wykazują jednak podobne zmiany neuropatologiczne podczas badań autopsyjnych24.

Czynniki ryzyka otępienia z ciałami Lewy’ego

Zidentyfikowano kilka czynników ryzyka, które mogą zwiększać prawdopodobieństwo rozwoju otępienia z ciałami Lewy’ego. Badacze nie są jednak w stanie jednoznacznie określić, dlaczego u niektórych osób rozwijają się ciała Lewy’ego, a u innych nie25.

Wiek i płeć

Wiek jest uznawany za najważniejszy znany czynnik ryzyka rozwoju otępienia z ciałami Lewy’ego2627:

  • Choroba zazwyczaj rozwija się u osób powyżej 50. roku życia28
  • Średni wiek zachorowania wynosi około 75 lat29
  • Otępienie z ciałami Lewy’ego rzadko występuje u osób młodszych

Płeć również stanowi czynnik ryzyka – mężczyźni chorują częściej niż kobiety303132. Badania wskazują również na różnice w obrazie klinicznym DLB w zależności od płci:

Czynniki genetyczne

Mimo że otępienie z ciałami Lewy’ego nie jest typowo uznawane za chorobę dziedziczną, zidentyfikowano kilka wariantów genetycznych, które mogą zwiększać ryzyko jej rozwoju3536:

  • Gen APOE (kodujący apolipoproteinę E) – wariant ε4 zwiększa ryzyko rozwoju zarówno choroby Alzheimera, jak i DLB373839
  • Gen GBA (glukocerebrozydaza) – zwiększa ryzyko zarówno choroby Parkinsona, jak i DLB404142
  • Gen SNCA (alfa-synukleina) – mutacje w tym genie prowadzą do powstawania nieprawidłowych form białka alfa-synukleiny, które mają tendencję do agregacji434445
  • Gen SNCB (beta-synukleina) – warianty tego genu prowadzą do produkcji zmienionego białka beta-synukleiny, które umożliwia gromadzenie się alfa-synukleiny46

Pomimo tych odkryć, mutacje genetyczne jako przyczyna DLB są nadal uważane za rzadkie47. Większość przypadków otępienia z ciałami Lewy’ego to sporadyczne formy choroby, bez wyraźnej historii rodzinnej48.

Współistniejące stany chorobowe

Niektóre schorzenia są powiązane ze zwiększonym ryzykiem rozwoju otępienia z ciałami Lewy’ego49:

  • Zaburzenie zachowania w fazie snu REM (RBD) – występowanie tego zaburzenia często poprzedza rozwój DLB o kilka, a nawet kilkadziesiąt lat5051
  • Choroba Parkinsona – osoby z chorobą Parkinsona mają zwiększone ryzyko rozwoju otępienia5253
  • Zaburzenia węchu – utrata węchu jest powiązana z wyższym ryzykiem DLB54

Istnieją dowody sugerujące, że inne choroby przewlekłe mogą również zwiększać ryzyko DLB:

  • Nadciśnienie tętnicze
  • Cukrzyca
  • Hiperlipidemia55
  • Depresja – badania wskazują, że depresja może zwiększać ryzyko DLB silniej niż w przypadku choroby Alzheimera czy choroby Parkinsona56

Czynniki środowiskowe

Rola czynników środowiskowych w rozwoju otępienia z ciałami Lewy’ego nie jest dobrze poznana. Aktualne badania wskazują, że środowisko może wpływać na śmiertelność pacjentów z DLB57, jednak nie zidentyfikowano konkretnych czynników środowiskowych, które jednoznacznie przyczyniałyby się do rozwoju tej choroby58.

Naukowcy sugerują, że na rozwój otępienia z ciałami Lewy’ego może wpływać kombinacja mutacji genowych, czynników środowiskowych i naturalnego procesu starzenia się59. Badania nad specyficznymi przyczynami środowiskowymi są nadal w toku.

Mechanizmy patogenetyczne

Patogeneza otępienia z ciałami Lewy’ego jest złożona i obejmuje kilka powiązanych ze sobą mechanizmów uszkodzenia komórek nerwowych.

Agregacja alfa-synukleiny

Kluczowym wydarzeniem w patogenezie DLB jest nieprawidłowe fałdowanie i agregacja białka alfa-synukleiny60. W normalnych warunkach alfa-synukleina pełni rolę w komunikacji między komórkami nerwowymi, pomagając w regulacji uwalniania neurotransmiterów61. Jednak w DLB dochodzi do:

  • Nieprawidłowego fałdowania cząsteczek alfa-synukleiny
  • Agregacji źle sfałdowanych białek w komórkach nerwowych
  • Formowania się ciał Lewy’ego i neurytów Lewy’ego
  • Rozprzestrzeniania się patologii – nieprawidłowo sfałdowana alfa-synukleina może indukować nieprawidłowe fałdowanie kolejnych cząsteczek tego białka62

Dysfunkcja mitochondriów i stres oksydacyjny

Mutacje genetyczne, toksyny środowiskowe i procesy związane ze starzeniem mogą prowadzić do nieprawidłowego fałdowania alfa-synukleiny poprzez63:

  • Dysfunkcję mitochondriów – zaburzenia w produkcji energii komórkowej
  • Stres oksydacyjny – nadmierne powstawanie wolnych rodników uszkadzających struktury komórkowe

Te procesy tworzą błędne koło, w którym agregacja alfa-synukleiny dodatkowo uszkadza mitochondria, zwiększając stres oksydacyjny i prowadząc do dalszej agregacji tego białka.

Zaburzenia funkcji lizosomów

Warianty genu GBA, związane ze zwiększonym ryzykiem DLB, wpływają na funkcje lizosomów – organelli komórkowych odpowiedzialnych za degradację i recykling składników komórkowych64. Nieprawidłowo działające lizosomy zaburzają proces rozkładu alfa-synukleiny, zwiększając ryzyko jej akumulacji i tworzenia ciał Lewy’ego.

Uszkodzenie neuronów i ich połączeń

Choroba ciał Lewy’ego prowadzi do65:

  • Obniżenia poziomu ważnych neuroprzekaźników niezbędnych do przesyłania sygnałów w mózgu
  • Uszkodzenia połączeń między komórkami nerwowymi
  • Ostatecznie – śmierci neuronów

Neurony wytwarzające dopaminę wydają się szczególnie wrażliwe na uszkodzenia związane z ciałami Lewy’ego66. Dopamina odgrywa ważną rolę w procesach poznawczych, motywacji, zachowaniu i kontroli ruchu, dlatego jej niedobór prowadzi do charakterystycznych objawów DLB.

Lokalizacja zmian patologicznych

Objawy otępienia z ciałami Lewy’ego zależą od lokalizacji ciał Lewy’ego w mózgu67. Zmiany patologiczne występują w różnych obszarach mózgu, co wpływa na szeroki zakres funkcji:

  • Kora mózgowa – odpowiedzialna za funkcje poznawcze i percepcję
  • Kora limbiczna i hipokamp – związane z pamięcią i emocjami
  • Zwoje podstawy – kontrolujące ruch
  • Pień mózgu – regulujący podstawowe funkcje życiowe i sen
  • Drogi węchowe – odpowiedzialne za zmysł węchu68

Wzajemne relacje z innymi chorobami neurodegeneracyjnymi

Otępienie z ciałami Lewy’ego często współwystępuje z innymi chorobami neurodegeneracyjnymi, co dodatkowo komplikuje obraz kliniczny i przebieg choroby.

Spektrum chorób z ciałami Lewy’ego

Otępienie z ciałami Lewy’ego i otępienie w chorobie Parkinsona są uważane za część spektrum tej samej choroby, określanej jako choroba z ciałami Lewy’ego (Lewy body disease)6970. Choć objawy kliniczne mogą się różnić, obie jednostki charakteryzują się obecnością ciał Lewy’ego w mózgu i podobnymi zmianami neuropatologicznymi71.

Różnice między tymi jednostkami dotyczą głównie chronologii objawów:

  • W otępieniu z ciałami Lewy’ego – problemy poznawcze i halucynacje pojawiają się wcześnie w stosunku do objawów ruchowych72
  • W otępieniu w chorobie Parkinsona – otępienie rozwija się po kilku latach trwania objawów ruchowych73

Współistnienie z chorobą Alzheimera

U wielu pacjentów z otępieniem z ciałami Lewy’ego występują również zmiany patologiczne charakterystyczne dla choroby Alzheimera74:

  • Blaszki amyloidowe
  • Splątki neurofibrylarne

Współwystępowanie zmian patologicznych charakterystycznych dla DLB i choroby Alzheimera jest szczególnie częste u osób powyżej 80. roku życia75. U takich pacjentów objawy otępienia są często bardziej nasilone i choroba szybciej postępuje.

Badania autopsyjne kobiet z otępieniem z ciałami Lewy’ego częściej wykazują mieszaną patologię (współistnienie zmian charakterystycznych dla choroby ciał Lewy’ego i choroby Alzheimera) niż u mężczyzn, u których częściej stwierdza się „czystą” chorobę ciał Lewy’ego76.

Otępienie mieszane

Termin „otępienie mieszane” (mixed dementia) odnosi się do przypadków, gdy u pacjenta współwystępują cechy charakterystyczne dla więcej niż jednego typu otępienia77. Patologia leżąca u podstaw chorób takich jak DLB i choroba Alzheimera może się zazębiać, prowadząc do wspólnych cech i objawów.

Otępienie z ciałami Lewy’ego może być trudne do zdiagnozowania we wczesnym stadium, ponieważ objawy mogą początkowo przypominać chorobę Alzheimera lub choroby psychiczne, takie jak schizofrenia78. DLB może również występować równocześnie z innymi formami otępienia.

Postęp w zrozumieniu przyczyn otępienia z ciałami Lewy’ego

Badania nad przyczynami otępienia z ciałami Lewy’ego są intensywnie prowadzone, a naukowcy stale poszerzają naszą wiedzę na temat tej choroby.

Aktualne kierunki badań

Naukowcy badają wiele aspektów otępienia z ciałami Lewy’ego, aby lepiej zrozumieć jego przyczyny i mechanizmy79:

  • Badania genetyczne – identyfikacja wariantów genów zwiększających ryzyko DLB
  • Badania biomarkerów – poszukiwanie specyficznych wskaźników biologicznych, które mogłyby pomóc w diagnozowaniu choroby
  • Badania nad mechanizmami agregacji alfa-synukleiny i jej rozprzestrzeniania się w mózgu
  • Badania interakcji między patologią alfa-synukleiny a innymi procesami neurodegeneracyjnymi

Lepsze zrozumienie mechanizmów leżących u podstaw choroby może prowadzić do opracowania skuteczniejszych metod diagnostycznych i terapeutycznych80.

Wyzwania w badaniach nad etiologią DLB

Badania nad przyczynami otępienia z ciałami Lewy’ego napotykają kilka wyzwań:

  • Heterogenność genetyczna – DLB wydaje się być chorobą genetycznie heterogenną, z rzadkim udziałem patogennych mutacji przyczynowych i stosunkowo częstymi czynnikami ryzyka81
  • Współwystępowanie z innymi chorobami neurodegeneracyjnymi – utrudnia przypisanie objawów do konkretnej patologii
  • Trudności diagnostyczne – brak jednoznacznych biomarkerów diagnostycznych, a diagnoza pewna możliwa jest dopiero po badaniu pośmiertnym82
  • Niedoreprezentowanie kobiet w badaniach klinicznych83

Znaczenie badań dla praktyki klinicznej

Zrozumienie etiologii i patogenezy otępienia z ciałami Lewy’ego ma kluczowe znaczenie dla praktyki klinicznej84:

  • Poprawa diagnostyki – opracowanie lepszych kryteriów diagnostycznych zwiększających czułość i swoistość rozpoznania
  • Optymalizacja leczenia – dostosowanie terapii do mechanizmów choroby
  • Unikanie powikłań – pacjenci z DLB wykazują nadwrażliwość na leki neuroleptyczne, co może prowadzić do poważnych reakcji niepożądanych8586

Właściwa diagnoza jest kluczowa dla zapewnienia najlepszego leczenia, maksymalizacji jego skuteczności i ograniczenia działań niepożądanych.

Mimo postępów w zrozumieniu otępienia z ciałami Lewy’ego, nadal nie ma leczenia przyczynowego. Dostępne terapie są ukierunkowane na łagodzenie objawów i poprawę jakości życia pacjentów87. Prowadzone badania dają jednak nadzieję na opracowanie w przyszłości skuteczniejszych metod zapobiegania i leczenia tej choroby.

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 12.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Dementia with Lewy bodies (DLB) | Symptoms & Causes | alz.org
    https://www.alz.org/alzheimers-dementia/what-is-dementia/types-of-dementia/dementia-with-lewy-bodies
    Dementia with Lewy bodies (DLB) is a type of progressive dementia that leads to a decline in thinking, reasoning and independent function. […] Dementia with Lewy bodies is one of the causes of dementia, alongside other types of dementia like Alzheimer’s disease and vascular dementia. […] Researchers have not yet identified any specific causes of dementia with Lewy bodies. Most people diagnosed with DLB have no family history of the disorder, and no genes linked to DLB have been conclusively identified.
  • #2 What Are the Seven Stages of Lewy Body Dementia? 10 Early Signs
    https://www.medicinenet.com/what_are_the_seven_stages_of_lewy_body_dementia/article.htm
    Lewy body dementia (LBD) or dementia with Lewy bodies (DLB) is associated with protein deposits in the brain that cause disruptions in the normal functioning of the brain. […] Dementia is caused by damage to the brain cells in specific regions of the brain that deal with a persons ability to remember and think. This damage is referred to as neurodegenerative changes and can be caused by any of the diseases that include: […] Dementia caused by neurodegenerative changes in the brain is permanent and worsens over time. […] Lewy body dementia (LBD) is usually a progressive fatal disease. […] It gets worse over time and that shortens lifespan. […] The average lifespan after diagnosis is between 8 and 12 years. […] However, this is highly variable, and some people may live much longer than this with proper care and symptomatic treatment.
  • #3 Lewy Body Dementia: Causes, Symptoms, and Diagnosis | National Institute on Aging
    https://www.nia.nih.gov/health/lewy-body-dementia/lewy-body-dementia-causes-symptoms-and-diagnosis
    LBD is a disease associated with abnormal deposits of a protein called alpha-synuclein in the brain. […] The precise cause of LBD is unknown, but scientists are learning more about its biology and genetics. […] For example, they know that an accumulation of Lewy bodies is associated with a loss of certain neurons in the brain that produce important neurotransmitters, which are chemicals that act as messengers between brain cells. […] Age is considered the greatest risk factor, with most people developing the disorder over age 50. […] Other known risk factors for LBD include the following: Certain diseases and health conditions, particularly REM sleep behavior disorder and loss of smell, are linked to a higher risk of LBD. […] While having a family member with LBD may increase a person’s risk, LBD is not typically considered a hereditary disease. […] However, in most cases, the cause of LBD is unknown. […] Scientists are exploring many avenues to develop better ways to diagnose and treat LBD.
  • #4 Clinical features and diagnosis of dementia with Lewy bodies – UpToDate
    https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-dementia-with-lewy-bodies
    Dementia with Lewy bodies (DLB) is one of the most common types of degenerative dementias, second to Alzheimer disease (AD). In addition to dementia, distinctive clinical features include visual hallucinations, parkinsonism, cognitive fluctuations, rapid eye movement (REM) sleep behavior disorder (RBD), dysautonomia, and neuroleptic sensitivity. […] The pathological hallmark of DLB is the presence of eosinophilic intracytoplasmic inclusions called Lewy bodies that contain aggregated alpha-synuclein. Lewy bodies are typically present in the deep cortical layers throughout the brain, especially in anterior frontal and temporal lobes, cingulate gyrus, and insula. […] Clinical diagnostic criteria for DLB are continually being refined to improve specificity and sensitivity. Appropriate diagnosis is critical in order to provide the best treatment in regard to maximizing efficacy and limiting adverse effects.
  • #5 Dementia with Lewy Bodies | Parkinson’s Foundation
    https://www.parkinson.org/understanding-parkinsons/non-movement-symptoms/dementia/lewy-bodies
    Approximately 1.4 million people in the U.S. are estimated to live with dementia with Lewy bodies (DLB), a progressive brain disorder also known as Lewy body dementia. The journey for people living with this difficult to diagnose, progressive condition can be especially complex. […] Dementia with Lewy bodies is diagnosed when cognitive decline (thinking changes) is an early symptom, occurring before or within a year of the onset of movement symptoms. […] The protein alpha-synuclein is involved in both DLB and PD. In these diseases, damaged alpha-synuclein folds into an irregular shape and forms toxic clumps known as Lewy bodies that alter the way brain cells work. Because of this, both dementia with Lewy bodies and Parkinsons disease are sometimes referred collectively as Lewy body diseases. How these toxic clumps lead to disease continues to be an intense area of research.
  • #6 Dementia With Lewy Bodies and Parkinson Disease Dementia – Brain, Spinal Cord, and Nerve Disorders – Merck Manual Consumer Version
    https://www.merckmanuals.com/home/brain-spinal-cord-and-nerve-disorders/delirium-and-dementia/dementia-with-lewy-bodies-and-parkinson-disease-dementia
    Dementia with Lewy bodies is progressive loss of mental function characterized by the development of Lewy bodies in nerve cells. […] Dementia with Lewy bodies usually develops in people older than 60. […] In dementia with Lewy bodies and Parkinson disease dementia, abnormal round deposits of a protein (called Lewy bodies) form in nerve cells. Lewy bodies result in the death of nerve cells. […] In this disorder, synuclein (a protein in the brain that helps nerve cells communicate) changes shape (misfolds) and slowly accumulates mostly in the brain but also in the digestive tract and heart. These abnormal deposits of synuclein are called Lewy bodies. The misfolded synuclein in Lewy bodies triggers more synuclein to misfold, resulting in the formation of more Lewy bodies. Brain damage results from the accumulation of Lewy bodies.
  • #7 Causes of dementia – NHS
    https://www.nhs.uk/conditions/dementia/about-dementia/causes/
    Dementia with Lewy bodies is closely related to Parkinson’s disease and often has some of the same symptoms, including difficulty with movement and a higher risk of falls. […] Lewy bodies are tiny clumps of a protein called alpha-synuclein that can develop inside brain cells. […] These clumps damage the way the cells work and communicate with each other, and the brain cells eventually die.
  • #8 Clinical features and diagnosis of dementia with Lewy bodies – UpToDate
    https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-dementia-with-lewy-bodies
    Dementia with Lewy bodies (DLB) is one of the most common types of degenerative dementias, second to Alzheimer disease (AD). In addition to dementia, distinctive clinical features include visual hallucinations, parkinsonism, cognitive fluctuations, rapid eye movement (REM) sleep behavior disorder (RBD), dysautonomia, and neuroleptic sensitivity. […] The pathological hallmark of DLB is the presence of eosinophilic intracytoplasmic inclusions called Lewy bodies that contain aggregated alpha-synuclein. Lewy bodies are typically present in the deep cortical layers throughout the brain, especially in anterior frontal and temporal lobes, cingulate gyrus, and insula. […] Clinical diagnostic criteria for DLB are continually being refined to improve specificity and sensitivity. Appropriate diagnosis is critical in order to provide the best treatment in regard to maximizing efficacy and limiting adverse effects.
  • #9 Dementia with Lewy bodies | Radiology Reference Article | Radiopaedia.org
    https://radiopaedia.org/articles/dementia-with-lewy-bodies?lang=us
    Dementia with Lewy bodies (DLB), also known as Lewy body disease, is a neurodegenerative disease (a synucleinopathy to be specific) related to Parkinson disease. […] Dementia with Lewy bodies presents in older patients (onset typically in 50-70 years of age), and is sporadic. […] It is the second most common neurodegenerative cause of dementia in older patients, after Alzheimer disease, accounting for 15-20% of cases. […] The characteristic feature of dementia with Lewy bodies is (not surprisingly) the accumulation of Lewy bodies throughout the brain. These intracellular inclusions result from the aggregation of misfolded -synuclein. […] Lewy bodies are seen in greatest concentrations in the midbrain, hypothalamus, basal ganglia, inferior olives, brainstem reticular formation, and dentate nuclei of the cerebellum.
  • #10 Lewy Body Dementia: Causes, Symptoms, and Diagnosis | National Institute on Aging
    https://www.nia.nih.gov/health/lewy-body-dementia/lewy-body-dementia-causes-symptoms-and-diagnosis
    LBD is a disease associated with abnormal deposits of a protein called alpha-synuclein in the brain. […] The precise cause of LBD is unknown, but scientists are learning more about its biology and genetics. […] For example, they know that an accumulation of Lewy bodies is associated with a loss of certain neurons in the brain that produce important neurotransmitters, which are chemicals that act as messengers between brain cells. […] Age is considered the greatest risk factor, with most people developing the disorder over age 50. […] Other known risk factors for LBD include the following: Certain diseases and health conditions, particularly REM sleep behavior disorder and loss of smell, are linked to a higher risk of LBD. […] While having a family member with LBD may increase a person’s risk, LBD is not typically considered a hereditary disease. […] However, in most cases, the cause of LBD is unknown. […] Scientists are exploring many avenues to develop better ways to diagnose and treat LBD.
  • #11 Lewy Body Dementia: Symptoms, Causes, Diagnosis, and Treatment
    https://www.everydayhealth.com/dementia/lewy-body-dementia/
    Lewy body dementia is a type of dementia (cognitive impairment that interferes with daily activities) caused by deposits of a protein, called alpha-synuclein, in the brain. These deposits form clumps, called Lewy bodies, that doctors can see under a microscope. Its likely the second most common type of dementia after Alzheimers disease. […] Lewy body dementia develops when abnormal clumps of a protein called alpha-synuclein build up in the brain. These clumps, called Lewy bodies, disrupt normal brain function and lead to the widespread death of neurons (brain cells). […] Lewy body dementia causes the death of neurons that produce two key neurotransmitters, or brain chemicals: acetylcholine and dopamine. Acetylcholine is important for learning and memory, while dopamine plays a role in thinking, movement, motivation, sleep, and mood.
  • #12 Lewy Bodies Disease – Symptoms, Causes and Treatments – UC Health
    https://www.uchealth.com/en/conditions/lewy-bodies-disease
    Dementia with Lewy bodies (DLB) is a form of progressive dementia. It’s caused by the decay of the tissues in the brain. […] The decay or deterioration of brain tissue causes dementia with Lewy bodies. DLB may be genetic. But it is not always clear why someone develops DLB. Lewy bodies in the brain affect substances called neurotransmitters. […] A lack of dopamine causes movement problems, such as those seen in PD. […] When Lewy bodies build up in these areas, they use up the acetylcholine, causing symptoms of dementia.
  • #13 Lewy Body Dementia: Symptoms, Causes, Diagnosis, and Treatment
    https://www.everydayhealth.com/dementia/lewy-body-dementia/
    Lewy body dementia is a type of dementia (cognitive impairment that interferes with daily activities) caused by deposits of a protein, called alpha-synuclein, in the brain. These deposits form clumps, called Lewy bodies, that doctors can see under a microscope. Its likely the second most common type of dementia after Alzheimers disease. […] Lewy body dementia develops when abnormal clumps of a protein called alpha-synuclein build up in the brain. These clumps, called Lewy bodies, disrupt normal brain function and lead to the widespread death of neurons (brain cells). […] Lewy body dementia causes the death of neurons that produce two key neurotransmitters, or brain chemicals: acetylcholine and dopamine. Acetylcholine is important for learning and memory, while dopamine plays a role in thinking, movement, motivation, sleep, and mood.
  • #14 Causes of Dementia with Lewy bodies (DLB) | Stanford Health Care
    https://stanfordhealthcare.org/medical-conditions/brain-and-nerves/dementia-with-lewy-bodies/causes.html
    Dementia with Lewy bodies (DLB) is caused by degeneration of brain tissue. Lewy bodies in the brain affect substances called neurotransmitters. […] A lack of dopamine causes movement problems such as those seen in Parkinson’s disease (PD). […] When Lewy bodies build up in these areas, they lead to a deficiency in acetylcholine, causing symptoms of dementia.
  • #15 Lewy Bodies Disease – Symptoms, Causes and Treatments – UC Health
    https://www.uchealth.com/en/conditions/lewy-bodies-disease
    Dementia with Lewy bodies (DLB) is a form of progressive dementia. It’s caused by the decay of the tissues in the brain. […] The decay or deterioration of brain tissue causes dementia with Lewy bodies. DLB may be genetic. But it is not always clear why someone develops DLB. Lewy bodies in the brain affect substances called neurotransmitters. […] A lack of dopamine causes movement problems, such as those seen in PD. […] When Lewy bodies build up in these areas, they use up the acetylcholine, causing symptoms of dementia.
  • #16 Causes of Dementia with Lewy bodies (DLB) | Stanford Health Care
    https://stanfordhealthcare.org/medical-conditions/brain-and-nerves/dementia-with-lewy-bodies/causes.html
    Dementia with Lewy bodies (DLB) is caused by degeneration of brain tissue. Lewy bodies in the brain affect substances called neurotransmitters. […] A lack of dopamine causes movement problems such as those seen in Parkinson’s disease (PD). […] When Lewy bodies build up in these areas, they lead to a deficiency in acetylcholine, causing symptoms of dementia.
  • #17 Lewy body dementia – Wikipedia
    https://en.wikipedia.org/wiki/Lewy_body_dementia
    Lewy body dementia (LBD) is an umbrella term for two similar and common subtypes of dementia: dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD). […] The exact cause is unknown, but involves widespread deposits of abnormal clumps of protein that form in neurons of the diseased brain. […] The fifth revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) gives Lewy body disease as the causative subtype of dementia with Lewy bodies, and Parkinson’s disease as the causative subtype of Parkinson’s disease dementia. […] Dementia with Lewy bodies and Parkinson’s disease dementia are similar in many ways, suggesting there may be a common pathophysiological mechanism, with PDD and DLB at opposite ends of a Lewy body disease spectrum, and a shared component of protein deposits in Lewy bodies and Lewy neurites.
  • #18 Lewy body dementia – Symptoms and causes – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/lewy-body-dementia/symptoms-causes/syc-20352025
    Lewy body dementia is characterized by the buildup of proteins into masses known as Lewy bodies. This protein also is associated with Parkinson’s disease. People who have Lewy bodies in their brains also have the plaques and tangles associated with Alzheimer’s disease. […] A few factors seem to increase the risk of developing Lewy body dementia, including: […] Those who have a family member with Lewy body dementia or Parkinson’s disease are at greater risk.
  • #19 Dementia with Lewy bodies (DLB): what is it and what causes it? | Alzheimer’s Society
    https://www.alzheimers.org.uk/about-dementia/types-dementia/dementia-with-lewy-bodies
    Having Lewy body disease doesn’t mean that a person’s dementia is only caused by the build-up of Lewy bodies in their brain. […] Many people with DLB also have a build-up of other proteins that cause Alzheimer’s disease. This is common in people over about 80 years old. For people with both DLB and Alzheimer’s, dementia symptoms are often more severe and progress more quickly. […] Almost all people who develop DLB have a sporadic form, which means that the main cause is unknown. Some genes may increase the risk of developing DLB.
  • #20 Lewy body dementia – Wikipedia
    https://en.wikipedia.org/wiki/Lewy_body_dementia
    Lewy body dementia (LBD) is an umbrella term for two similar and common subtypes of dementia: dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD). […] The exact cause is unknown, but involves widespread deposits of abnormal clumps of protein that form in neurons of the diseased brain. […] The fifth revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) gives Lewy body disease as the causative subtype of dementia with Lewy bodies, and Parkinson’s disease as the causative subtype of Parkinson’s disease dementia. […] Dementia with Lewy bodies and Parkinson’s disease dementia are similar in many ways, suggesting there may be a common pathophysiological mechanism, with PDD and DLB at opposite ends of a Lewy body disease spectrum, and a shared component of protein deposits in Lewy bodies and Lewy neurites.
  • #21 Lewy body dementia – Wikipedia
    https://en.wikipedia.org/wiki/Lewy_body_dementia
    DSM-5 gives Lewy body disease as the causative subtype of DLB, and Parkinson’s disease as the causative subtype of PDD. […] Despite differences in the timing of the appearance of symptoms, the two dementias „show remarkably convergent neuropathological changes at autopsy”. […] The relationship between Parkinson’s disease dementia and dementia with Lewy bodies is unclear as of 2020, but there is likely to be genetic overlap, and the two conditions may represent different points on a continuum.
  • #22 Dementia with Lewy Bodies | Parkinson’s Foundation
    https://www.parkinson.org/understanding-parkinsons/non-movement-symptoms/dementia/lewy-bodies
    Approximately 1.4 million people in the U.S. are estimated to live with dementia with Lewy bodies (DLB), a progressive brain disorder also known as Lewy body dementia. The journey for people living with this difficult to diagnose, progressive condition can be especially complex. […] Dementia with Lewy bodies is diagnosed when cognitive decline (thinking changes) is an early symptom, occurring before or within a year of the onset of movement symptoms. […] The protein alpha-synuclein is involved in both DLB and PD. In these diseases, damaged alpha-synuclein folds into an irregular shape and forms toxic clumps known as Lewy bodies that alter the way brain cells work. Because of this, both dementia with Lewy bodies and Parkinsons disease are sometimes referred collectively as Lewy body diseases. How these toxic clumps lead to disease continues to be an intense area of research.
  • #23 Dementia with Lewy bodies | Radiology Reference Article | Radiopaedia.org
    https://radiopaedia.org/articles/dementia-with-lewy-bodies?lang=us
    The relationship between Parkinson disease and dementia with Lewy bodies is controversial, with some authors believing they are different manifestations of the same disease, whereas others believe they are distinct entities. […] In dementia with Lewy bodies, dementia precedes or accompanies parkinsonism (or at least becomes clinically evident within 12 months of presentation). […] Patients with Parkinson disease, on the other hand, will not infrequently also develop dementia. However, it typically occurs years after the onset of parkinsonian symptoms. […] Unlike Parkinson disease, dementia with Lewy bodies respond less readily to L-dopa and also may have severe sensitivity reactions to neuroleptic drugs, such as rigidity, reduced consciousness, pyrexia, falling, postural hypotension and collapse. […] Lewy body dementia also responds favourably to acetylcholinesterase inhibitors, even more so than Alzheimer disease.
  • #24 Lewy body dementia – Wikipedia
    https://en.wikipedia.org/wiki/Lewy_body_dementia
    DSM-5 gives Lewy body disease as the causative subtype of DLB, and Parkinson’s disease as the causative subtype of PDD. […] Despite differences in the timing of the appearance of symptoms, the two dementias „show remarkably convergent neuropathological changes at autopsy”. […] The relationship between Parkinson’s disease dementia and dementia with Lewy bodies is unclear as of 2020, but there is likely to be genetic overlap, and the two conditions may represent different points on a continuum.
  • #25 Dementia with Lewy Bodies
    https://www.massgeneral.org/neurology/treatments-and-services/dementia-with-lewy-bodies/
    Dementia with Lewy bodies occurs when protein deposits disrupt brain function. […] Dementia with Lewy bodies (DLB) is the second most common type of neurodegenerative dementia after Alzheimer’s disease. It occurs when protein deposits called Lewy bodies form in the brain. The Lewy bodies disrupt the normal functioning of brain cells, resulting in an array of neurological symptoms related to sleep, movement, personality, and cognitive abilities. […] Experts know that DLB is caused by a build-up of protein deposits called Lewy bodies, but they don’t understand what causes some people to develop Lewy bodies while other people don’t. […] The current understanding is that the cause of dementia with Lewy bodies is a mix of factors including genetics and environmental factors. […] Dementia with Lewy bodies is caused by protein deposits in the brain, called Lewy bodies, but experts don’t understand why some people develop these deposits while others don’t.
  • #26 Dementia with Lewy Bodies Risk Factors | Alzheimer’s Research UK
    https://www.alzheimersresearchuk.org/dementia-information/types-of-dementia/dementia-with-lewy-bodies/risk-factors/
    Age is the biggest known risk factor for the development of Dementia with Lewy bodies. […] As with many other types of dementia, there are many risk factors for dementia with Lewy bodies that interact together to cause the disease. […] Age is the biggest risk factor for the development of DLB, this means that the older we are the more likely it becomes. […] We know that conditions like high blood pressure, high cholesterol and diabetes are risk factors for other types of dementia like Alzheimer’s disease and there is evidence to suggest they are risk factors for the development of DLB too. […] Men are more likely to get DLB than women, and people with a family history of Parkinson’s disease or DLB have a higher risk too. […] Some research studies have found several genes linked to a higher risk of DLB, including a known risk gene for Alzheimer’s. […] While these discoveries help us to understand more about the disease, having one of these risk genes does not mean you will definitely go on to develop it. […] There is no test available on the NHS for risk genes associated with DLB or Alzheimer’s.
  • #27 Lewy Body Dementia: Causes, Symptoms, and Diagnosis | National Institute on Aging
    https://www.nia.nih.gov/health/lewy-body-dementia/lewy-body-dementia-causes-symptoms-and-diagnosis
    LBD is a disease associated with abnormal deposits of a protein called alpha-synuclein in the brain. […] The precise cause of LBD is unknown, but scientists are learning more about its biology and genetics. […] For example, they know that an accumulation of Lewy bodies is associated with a loss of certain neurons in the brain that produce important neurotransmitters, which are chemicals that act as messengers between brain cells. […] Age is considered the greatest risk factor, with most people developing the disorder over age 50. […] Other known risk factors for LBD include the following: Certain diseases and health conditions, particularly REM sleep behavior disorder and loss of smell, are linked to a higher risk of LBD. […] While having a family member with LBD may increase a person’s risk, LBD is not typically considered a hereditary disease. […] However, in most cases, the cause of LBD is unknown. […] Scientists are exploring many avenues to develop better ways to diagnose and treat LBD.
  • #28 Lewy Body Dementia: Causes, Symptoms, and Diagnosis | National Institute on Aging
    https://www.nia.nih.gov/health/lewy-body-dementia/lewy-body-dementia-causes-symptoms-and-diagnosis
    LBD is a disease associated with abnormal deposits of a protein called alpha-synuclein in the brain. […] The precise cause of LBD is unknown, but scientists are learning more about its biology and genetics. […] For example, they know that an accumulation of Lewy bodies is associated with a loss of certain neurons in the brain that produce important neurotransmitters, which are chemicals that act as messengers between brain cells. […] Age is considered the greatest risk factor, with most people developing the disorder over age 50. […] Other known risk factors for LBD include the following: Certain diseases and health conditions, particularly REM sleep behavior disorder and loss of smell, are linked to a higher risk of LBD. […] While having a family member with LBD may increase a person’s risk, LBD is not typically considered a hereditary disease. […] However, in most cases, the cause of LBD is unknown. […] Scientists are exploring many avenues to develop better ways to diagnose and treat LBD.
  • #29 Epidemiology, pathology, and pathogenesis of dementia with Lewy bodies – UpToDate
    https://www.uptodate.com/contents/epidemiology-pathology-and-pathogenesis-of-dementia-with-lewy-bodies
    Dementia with Lewy bodies (DLB) is one of the most common causes of dementia after Alzheimer disease (AD) and vascular dementia. […] DLB has been given various names over the years, which in part reflects the uncertainty as to whether it is one of several distinct disease entities with the shared common finding of limbic and cerebral cortical Lewy bodies, or whether it represents one point on a spectrum of Lewy body disease. […] This topic will describe the epidemiology, neuropathologic findings, and potential pathogenic mechanisms of DLB. […] DLB, although once considered rare, is recognized as a common cause of neurodegenerative dementia, affecting up to 5 percent of the general population and accounting for as much as 30 percent of all dementia cases. […] Incidence rates have been estimated at 0.1 percent per year in the general population but up to 3.2 percent for new dementia cases. […] Similar to other neurodegenerative diseases, the prevalence of DLB increases with age, with an average age at presentation of 75 years.
  • #30 Dementia with Lewy Bodies Risk Factors | Alzheimer’s Research UK
    https://www.alzheimersresearchuk.org/dementia-information/types-of-dementia/dementia-with-lewy-bodies/risk-factors/
    Age is the biggest known risk factor for the development of Dementia with Lewy bodies. […] As with many other types of dementia, there are many risk factors for dementia with Lewy bodies that interact together to cause the disease. […] Age is the biggest risk factor for the development of DLB, this means that the older we are the more likely it becomes. […] We know that conditions like high blood pressure, high cholesterol and diabetes are risk factors for other types of dementia like Alzheimer’s disease and there is evidence to suggest they are risk factors for the development of DLB too. […] Men are more likely to get DLB than women, and people with a family history of Parkinson’s disease or DLB have a higher risk too. […] Some research studies have found several genes linked to a higher risk of DLB, including a known risk gene for Alzheimer’s. […] While these discoveries help us to understand more about the disease, having one of these risk genes does not mean you will definitely go on to develop it. […] There is no test available on the NHS for risk genes associated with DLB or Alzheimer’s.
  • #31 What Are the Lewy Body Dementia Risk Factors Patients Should Know About? – Altoida
    https://altoida.com/blog/what-are-the-lewy-body-dementia-risk-factors-patients-should-know-about/
    Lewy body dementia is more prevalent in men than in women. […] Research suggests these conditions may also be risk factors for Lewy body dementia. […] A 2018 population-based study found that hypertension, diabetes mellitus, and hyperlipidemia are both risk factors for Alzheimers disease and Lewy body dementia. […] A 2013 case-control study found that depression increases Lewy body dementia risk more strongly than it does in Alzheimers disease and Parkinsons disease.
  • #32 About Lewy Body Dementia – Biggs Institute
    https://biggsinstitute.org/patient-care/lewy-body-dementia/
    Lewy body dementia, also referred to as dementia with Lewy bodies, is the second most common form of dementia in older adults. […] The exact causes of Lewy body dementia are unknown. […] Risk factors include: Family history: Having a family member with Lewy body dementia or Parkinson’s disease can increase risks of developing Lewy body dementia. […] Age: Risk increases after the age of 60. […] Gender: Men have an increased risk of being diagnosed with Lewy body dementia.
  • #33 Does dementia with Lewy bodies impact people differently based on sex? » Norman Fixel Institute for Neurological Diseases » University of Florida
    https://fixel.ufhealth.org/2023/01/30/does-dementia-with-lewy-bodies-impact-people-differently-based-on-sex/
    Your sex may impact the symptoms and signs of a developing brain diseases like dementia with Lewy bodies (DLB), a disease that causes memory and thinking problems along with other symptoms such as Parkinson-like movement changes, hallucinations, ups and downs in alertness, and acting out of dreams. […] Many studies show that DLB is more common in men, but this finding is inconsistent and varies by study approach. […] Women with DLB are typically under-represented in clinical trial research, said Dr. Chiu. […] Based on research with specific data on sex or gender, Drs. Chiu and Armstrong found the following conclusions: Visual hallucinations are more common and occur earlier in women with DLB, whereas Rapid Eye Movement (REM) sleep behavior disorder (acting out dreams) may be more common and occur earlier in men with DLB.
  • #34 Does dementia with Lewy bodies impact people differently based on sex? » Norman Fixel Institute for Neurological Diseases » University of Florida
    https://fixel.ufhealth.org/2023/01/30/does-dementia-with-lewy-bodies-impact-people-differently-based-on-sex/
    Parkinson-like movement changes appear more frequent in men with DLB, while frequency of fluctuations (ups and downs in alertness) appears similar between the sexes. […] Women tend to be older, have more memory and thinking changes at their first visit, and are delayed in meeting DLB diagnostic criteria compared to men. […] On autopsy, women are more likely to have mixed Lewy body disease and co-existing Alzheimer related pathology than so-called pure Lewy body disease, while men may present with either.
  • #35 Lewy Body Dementia: Causes, Symptoms, and Diagnosis | National Institute on Aging
    https://www.nia.nih.gov/health/lewy-body-dementia/lewy-body-dementia-causes-symptoms-and-diagnosis
    LBD is a disease associated with abnormal deposits of a protein called alpha-synuclein in the brain. […] The precise cause of LBD is unknown, but scientists are learning more about its biology and genetics. […] For example, they know that an accumulation of Lewy bodies is associated with a loss of certain neurons in the brain that produce important neurotransmitters, which are chemicals that act as messengers between brain cells. […] Age is considered the greatest risk factor, with most people developing the disorder over age 50. […] Other known risk factors for LBD include the following: Certain diseases and health conditions, particularly REM sleep behavior disorder and loss of smell, are linked to a higher risk of LBD. […] While having a family member with LBD may increase a person’s risk, LBD is not typically considered a hereditary disease. […] However, in most cases, the cause of LBD is unknown. […] Scientists are exploring many avenues to develop better ways to diagnose and treat LBD.
  • #36 Dementia with Lewy bodies: an update and outlook | Molecular Neurodegeneration | Full Text
    https://molecularneurodegeneration.biomedcentral.com/articles/10.1186/s13024-019-0306-8
    The strongest and most replicated genetic risk factors for DLB are unequivocally APOE 4 allele and Glucocerebrosidase (GBA). DLB patients are 8 times more likely to be carriers of GBA mutations than controls. […] DLB appears to be genetically heterogeneous, with a rare contribution of pathogenic causative mutations and relatively common risk factors, which may explain why DLB is a relatively common disorder, but with a reduced aggregation in families.
  • #37 Lewy Body Dementia (LBD): What It Is, Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/17815-lewy-body-dementia
    Lewy body dementia (LBD) is a common type of dementia that happens when clumps of proteins called Lewy bodies build up in your brain. They damage parts of your brain that affect cognition, behavior, movement and sleep. LBD is a progressive condition, meaning it gets worse over time. […] A buildup of Lewy bodies (proteins called alpha-synuclein) causes both dementia with Lewy bodies and Parkinsons disease dementia. When Lewy bodies build up in neurons, they cause damage to certain areas of your brain. […] Researchers dont know why some people develop LBD while others dont. Theres some thought that the combination of mutations in a persons genes, environmental risk factors and natural aging might lead to the development of LBD in some people. Research into specific causes is ongoing. […] One of the more recent discoveries toward identifying a cause of Lewy body dementia is the finding of an increasing number of gene mutations. Two genetic risk factors recently discovered are variants in the APOE and GBA genes.
  • #38 Lewy Body Dementia (LBD): What It Is, Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/17815-lewy-body-dementia
    APOE is already known to increase the risk of developing Alzheimers disease. Theres growing evidence that it also increases the risk for dementia with Lewy bodies. Similarly, the GBA gene increases the risk for both Parkinsons disease and dementia with Lewy bodies. Despite these findings, genetic changes as a cause of LBD are still considered rare by scientists. Most cases of Lewy body dementia arent thought to be inherited (passed down from parent to child).
  • #39 Dementia with Lewy bodies: an update and outlook | Molecular Neurodegeneration | Full Text
    https://molecularneurodegeneration.biomedcentral.com/articles/10.1186/s13024-019-0306-8
    The strongest and most replicated genetic risk factors for DLB are unequivocally APOE 4 allele and Glucocerebrosidase (GBA). DLB patients are 8 times more likely to be carriers of GBA mutations than controls. […] DLB appears to be genetically heterogeneous, with a rare contribution of pathogenic causative mutations and relatively common risk factors, which may explain why DLB is a relatively common disorder, but with a reduced aggregation in families.
  • #40 Lewy Body Dementia (LBD): What It Is, Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/17815-lewy-body-dementia
    Lewy body dementia (LBD) is a common type of dementia that happens when clumps of proteins called Lewy bodies build up in your brain. They damage parts of your brain that affect cognition, behavior, movement and sleep. LBD is a progressive condition, meaning it gets worse over time. […] A buildup of Lewy bodies (proteins called alpha-synuclein) causes both dementia with Lewy bodies and Parkinsons disease dementia. When Lewy bodies build up in neurons, they cause damage to certain areas of your brain. […] Researchers dont know why some people develop LBD while others dont. Theres some thought that the combination of mutations in a persons genes, environmental risk factors and natural aging might lead to the development of LBD in some people. Research into specific causes is ongoing. […] One of the more recent discoveries toward identifying a cause of Lewy body dementia is the finding of an increasing number of gene mutations. Two genetic risk factors recently discovered are variants in the APOE and GBA genes.
  • #41 Lewy Body Dementia (LBD): What It Is, Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/17815-lewy-body-dementia
    APOE is already known to increase the risk of developing Alzheimers disease. Theres growing evidence that it also increases the risk for dementia with Lewy bodies. Similarly, the GBA gene increases the risk for both Parkinsons disease and dementia with Lewy bodies. Despite these findings, genetic changes as a cause of LBD are still considered rare by scientists. Most cases of Lewy body dementia arent thought to be inherited (passed down from parent to child).
  • #42 Dementia with Lewy bodies: an update and outlook | Molecular Neurodegeneration | Full Text
    https://molecularneurodegeneration.biomedcentral.com/articles/10.1186/s13024-019-0306-8
    The strongest and most replicated genetic risk factors for DLB are unequivocally APOE 4 allele and Glucocerebrosidase (GBA). DLB patients are 8 times more likely to be carriers of GBA mutations than controls. […] DLB appears to be genetically heterogeneous, with a rare contribution of pathogenic causative mutations and relatively common risk factors, which may explain why DLB is a relatively common disorder, but with a reduced aggregation in families.
  • #43 Dementia with Lewy bodies: MedlinePlus GeneticsLock
    https://medlineplus.gov/genetics/condition/dementia-with-lewy-bodies/
    Dementia with Lewy bodies is a nervous system disorder characterized by a decline in intellectual function (dementia), a group of movement problems known as parkinsonism, visual hallucinations, sudden changes (fluctuations) in behavior and intellectual ability, and acting out dreams while asleep (REM sleep behavior disorder). This condition typically affects older adults, most often developing between ages 50 and 85. The life expectancy of individuals with dementia with Lewy bodies varies; people typically survive about 5 to 7 years after they are diagnosed. […] Variants (also called mutations) in genes known as SNCA and SNCB can cause dementia with Lewy bodies. The SNCA and SNCB genes provide instructions for making proteins, called alpha-synuclein and beta-synuclein, respectively, that are found primarily in the brain. Alpha-synuclein plays a role in communication between nerve cells (neurons), helping to regulate the release of chemical messengers (neurotransmitters). Beta-synuclein is likely involved in a process that allows neurons to change and adapt over time, which is necessary for learning and memory. Beta-synuclein may also prevent harmful accumulation of alpha-synuclein in neurons.
  • #44 Dementia with Lewy bodies: MedlinePlus GeneticsLock
    https://medlineplus.gov/genetics/condition/dementia-with-lewy-bodies/
    Changes in these four genes can lead to the formation of Lewy bodies, which are clusters of alpha-synuclein protein. SNCA gene variants result in misshapen alpha-synuclein proteins that cluster together (aggregate). SNCB gene variants lead to the production of an altered beta-synuclein protein that allows accumulation of alpha-synuclein. GBA1 gene variants are thought to disrupt the normal function of lysosomes. Research suggests that malfunctioning lysosomes impair the breakdown of alpha-synuclein, increasing the risk of its accumulation and the formation of Lewy bodies. […] In dementia with Lewy bodies, alpha-synuclein clusters accumulate inside and outside of neurons throughout the brain where they impair cell function and ultimately cause cell death. Neurons that produce the neurotransmitter dopamine seem to be particularly vulnerable to Lewy bodies. Dopamine has many important functions, including playing complex roles in cognition, motivation, behavior, and control of movement. Over time, the loss of dopamine-producing neurons can increasingly impair intellectual and motor function and the regulation of emotions, resulting in the signs and symptoms of dementia with Lewy bodies.
  • #45 Lewy Body Dementia: Causes and Symptoms | MyParkinsonsTeam
    https://www.myparkinsonsteam.com/resources/lewy-body-dementia-causes-and-symptoms
    The APOE gene, which makes protein apolipoprotein E, has been associated with dementia with Lewy bodies. […] These diseases have also been linked to mutations in SNCA (a gene controlling the production of alpha-synuclein) and LRRK2 (a gene that controls the production of a kinase protein). […] However, more research is needed to understand the complicated role of these genes and how they may be interacting.
  • #46 Dementia with Lewy bodies: MedlinePlus GeneticsLock
    https://medlineplus.gov/genetics/condition/dementia-with-lewy-bodies/
    Changes in these four genes can lead to the formation of Lewy bodies, which are clusters of alpha-synuclein protein. SNCA gene variants result in misshapen alpha-synuclein proteins that cluster together (aggregate). SNCB gene variants lead to the production of an altered beta-synuclein protein that allows accumulation of alpha-synuclein. GBA1 gene variants are thought to disrupt the normal function of lysosomes. Research suggests that malfunctioning lysosomes impair the breakdown of alpha-synuclein, increasing the risk of its accumulation and the formation of Lewy bodies. […] In dementia with Lewy bodies, alpha-synuclein clusters accumulate inside and outside of neurons throughout the brain where they impair cell function and ultimately cause cell death. Neurons that produce the neurotransmitter dopamine seem to be particularly vulnerable to Lewy bodies. Dopamine has many important functions, including playing complex roles in cognition, motivation, behavior, and control of movement. Over time, the loss of dopamine-producing neurons can increasingly impair intellectual and motor function and the regulation of emotions, resulting in the signs and symptoms of dementia with Lewy bodies.
  • #47 Lewy Body Dementia (LBD): What It Is, Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/17815-lewy-body-dementia
    APOE is already known to increase the risk of developing Alzheimers disease. Theres growing evidence that it also increases the risk for dementia with Lewy bodies. Similarly, the GBA gene increases the risk for both Parkinsons disease and dementia with Lewy bodies. Despite these findings, genetic changes as a cause of LBD are still considered rare by scientists. Most cases of Lewy body dementia arent thought to be inherited (passed down from parent to child).
  • #48 Dementia with Lewy bodies (DLB): what is it and what causes it? | Alzheimer’s Society
    https://www.alzheimers.org.uk/about-dementia/types-dementia/dementia-with-lewy-bodies
    Having Lewy body disease doesn’t mean that a person’s dementia is only caused by the build-up of Lewy bodies in their brain. […] Many people with DLB also have a build-up of other proteins that cause Alzheimer’s disease. This is common in people over about 80 years old. For people with both DLB and Alzheimer’s, dementia symptoms are often more severe and progress more quickly. […] Almost all people who develop DLB have a sporadic form, which means that the main cause is unknown. Some genes may increase the risk of developing DLB.
  • #49 Lewy Body Dementia: Causes, Symptoms, and Diagnosis | National Institute on Aging
    https://www.nia.nih.gov/health/lewy-body-dementia/lewy-body-dementia-causes-symptoms-and-diagnosis
    LBD is a disease associated with abnormal deposits of a protein called alpha-synuclein in the brain. […] The precise cause of LBD is unknown, but scientists are learning more about its biology and genetics. […] For example, they know that an accumulation of Lewy bodies is associated with a loss of certain neurons in the brain that produce important neurotransmitters, which are chemicals that act as messengers between brain cells. […] Age is considered the greatest risk factor, with most people developing the disorder over age 50. […] Other known risk factors for LBD include the following: Certain diseases and health conditions, particularly REM sleep behavior disorder and loss of smell, are linked to a higher risk of LBD. […] While having a family member with LBD may increase a person’s risk, LBD is not typically considered a hereditary disease. […] However, in most cases, the cause of LBD is unknown. […] Scientists are exploring many avenues to develop better ways to diagnose and treat LBD.
  • #50 Lewy Body Dementia Symptoms & Treatment | Pacific Brain Health Center
    https://www.pacificneuroscienceinstitute.org/brain-health/conditions-treatment/dementia/lewy-body-dementia/
    Also a core feature of DLB is the presence of REM sleep behavior disorder (RBD), typically preceding the cognitive and movement disorder by several years, even decades. […] The definitive diagnosis of DLB is, unfortunately, based on autopsy. Probable DLB is diagnosed based on the presence of dementia and two of the three core features: visual hallucinations, parkinsonism, and fluctuations of awareness. […] There are no treatments of DLB that are unique to the condition. Medications and treatments used to manage symptoms of parkinsonism, dementia, behavioral issues, and RBD are used based on testing in PD. […] While there are no curative treatments for Lewy Body dementia at this time, at Pacific Neuroscience Institute we are confident that accurate diagnosis is the first step in research opportunities and improved treatment and prevention of progression.
  • #51 Alzheimer’s Disease and Related Dementias | LA County Department of Public Health
    http://publichealth.lacounty.gov/healthybrainla/AlzheimersDementias/lewybodydementia.htm
    Lewy Body Dementia (LBD) is a progressive disease marked by brain changes that result in problems with thinking, movement, and behavior. It is the third most common cause of dementia. LBD commonly occurs in people over the age of 50, but it can also impact younger adults too. […] LBD is linked to an abnormal buildup of a protein called alpha-synuclein in the brain. This buildup forms clumps called Lewy bodies and impacts areas of the brain involved with thinking, movement, and behavior. The specific cause of LBD remains unknown. Researchers are still trying to understand what factors cause Lewy bodies to form. […] Age is the greatest known risk factor for LBD, mainly affecting people aged 50 or older. LBD is also more common among men than women. Rapid eye movement (REM) sleep disorders and a family history of LBD or Parkinsons disease may also increase the risk for LBD.
  • #52 Dementia with Lewy bodies | NHS inform
    https://www.nhsinform.scot/illnesses-and-conditions/brain-nerves-and-spinal-cord/dementia-with-lewy-bodies/
    Dementia with Lewy bodies is a common form of dementia. […] In dementia with Lewy bodies, small proteins known as Lewy bodies appear in the nerve cells of the brain. They then build up in the parts of the brain responsible for memory and muscle movement. […] Its not clear why this happens or how exactly the brain is damaged. But, its thought that the chemical signals between brain cells are disrupted. […] People who have Parkinsons disease are more likely to go on to develop dementia with Lewy bodies. This is known as Parkinsons disease dementia (PDD).
  • #53 What is Dementia with Lewy bodies? | Alzheimer’s Research UK
    https://www.alzheimersresearchuk.org/dementia-information/types-of-dementia/dementia-with-lewy-bodies/
    People who have Parkinson’s disease are more likely to go on to develop dementia. This is known as Parkinson’s disease dementia (PDD). […] Dementia with Lewy bodies and Parkinson’s disease dementia can affect people in very similar ways, and people will receive a diagnosis of one or the other dependent on the timing of certain symptoms. […] Lewy Body Dementia is a term that describes both DLB and PDD and can be useful in these situations.
  • #54 Lewy Body Dementia: Causes, Symptoms, and Diagnosis | National Institute on Aging
    https://www.nia.nih.gov/health/lewy-body-dementia/lewy-body-dementia-causes-symptoms-and-diagnosis
    LBD is a disease associated with abnormal deposits of a protein called alpha-synuclein in the brain. […] The precise cause of LBD is unknown, but scientists are learning more about its biology and genetics. […] For example, they know that an accumulation of Lewy bodies is associated with a loss of certain neurons in the brain that produce important neurotransmitters, which are chemicals that act as messengers between brain cells. […] Age is considered the greatest risk factor, with most people developing the disorder over age 50. […] Other known risk factors for LBD include the following: Certain diseases and health conditions, particularly REM sleep behavior disorder and loss of smell, are linked to a higher risk of LBD. […] While having a family member with LBD may increase a person’s risk, LBD is not typically considered a hereditary disease. […] However, in most cases, the cause of LBD is unknown. […] Scientists are exploring many avenues to develop better ways to diagnose and treat LBD.
  • #55 What Are the Lewy Body Dementia Risk Factors Patients Should Know About? – Altoida
    https://altoida.com/blog/what-are-the-lewy-body-dementia-risk-factors-patients-should-know-about/
    Lewy body dementia is more prevalent in men than in women. […] Research suggests these conditions may also be risk factors for Lewy body dementia. […] A 2018 population-based study found that hypertension, diabetes mellitus, and hyperlipidemia are both risk factors for Alzheimers disease and Lewy body dementia. […] A 2013 case-control study found that depression increases Lewy body dementia risk more strongly than it does in Alzheimers disease and Parkinsons disease.
  • #56 What Are the Lewy Body Dementia Risk Factors Patients Should Know About? – Altoida
    https://altoida.com/blog/what-are-the-lewy-body-dementia-risk-factors-patients-should-know-about/
    Lewy body dementia is more prevalent in men than in women. […] Research suggests these conditions may also be risk factors for Lewy body dementia. […] A 2018 population-based study found that hypertension, diabetes mellitus, and hyperlipidemia are both risk factors for Alzheimers disease and Lewy body dementia. […] A 2013 case-control study found that depression increases Lewy body dementia risk more strongly than it does in Alzheimers disease and Parkinsons disease.
  • #57
    https://link.springer.com/article/10.1007/s40120-018-0104-1
    Dementia with Lewy bodies is one of the most common causes of dementia. […] The disease is caused by an accumulation of alpha-synuclein protein within neurons in the brain; these protein aggregates are known as Lewy bodies. […] The incidence of DLB is strongly associated with increasing age and male gender. […] The environment has been observed to have an effect on the mortality of patients who suffer from DLB. […] Neuroleptic sensitivity is a widely recognized feature of DLB. […] This cholinergic deficiency is thought to contribute to the neuropsychiatric symptoms of DLB. […] The diagnosis of probable DLB can be made if one or more of the indicative biomarkers is associated with one or more of the aforementioned core clinical features. […] Genetics and fluid studies do not currently have any established utility in the diagnosis of DLB.
  • #58 Frontotemporal Dementia Vs Lewy Body Dementia (Clinical Differences)
    https://optoceutics.com/frontotemporal-dementia-vs-lewy-body-dementia-differences/?srsltid=AfmBOor-cXVi6hSzsB7Dvsf1po8BFxf7mlgOXpfNihO1pGsdRmN4Rfh-
    Many elements cause frontotemporal dementia (FTD) and Lewy body dementia (LBD). However, the exact cause is still not understood and more research needs to be done on factors such as genetics and environment. Let us look at the current understanding of these diseases: […] Genetic factors: FTD patients have abnormal proteins in their brains, while LBD patients have the development of Lewy bodies that contribute to the disease. […] Environmental factors: Lifestyle, diet, and toxin exposure may contribute to FTD development. However, there are no environmental factors that indicate a contribution to the development of LBD. […] Current research, causes, and treatment are still ongoing for FTD and LBD as researchers are trying to determine genetic and environmental causes. However, LBD may need additional biomarkers to help in treatment and diagnosis. To date, there is no prevention for FTD and LBD.
  • #59 What Causes Lewy Body Dementia? – The Kensington Falls Church | The Kensington Falls Church
    https://thekensingtonfallschurch.com/causes-of-lewy-body-dementia/
    Roughly 1 million Americans currently have Lewy body dementia (LBD). […] Research is underway studying the causes of Lewy body dementia. Some professionals hypothesize it’s caused by a combination of mutated genes, environmental risk factors, and natural aging. […] In LBD, a different kind of protein, alpha-synuclein, accumulates to create “Lewy bodies,” which similarly affect the brain’s ability to communicate.
  • #60 Lewy Body Dementia – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK482441/
    Lewy Body Dementia (LBD) encompasses two clinical entities: dementia with Lewy bodies and Parkinson disease dementia. […] The etiology of LBD is still unknown; however, genetics, environmental factors, and changes linked to aging may have a role and still require further research. […] Genetic mutations, environmental toxins, and the aging process can lead to alpha-synuclein misfolding and its accumulation in Lewy bodies via oxidative stress and mitochondrial dysfunction.
  • #61 Dementia with Lewy bodies: MedlinePlus GeneticsLock
    https://medlineplus.gov/genetics/condition/dementia-with-lewy-bodies/
    Dementia with Lewy bodies is a nervous system disorder characterized by a decline in intellectual function (dementia), a group of movement problems known as parkinsonism, visual hallucinations, sudden changes (fluctuations) in behavior and intellectual ability, and acting out dreams while asleep (REM sleep behavior disorder). This condition typically affects older adults, most often developing between ages 50 and 85. The life expectancy of individuals with dementia with Lewy bodies varies; people typically survive about 5 to 7 years after they are diagnosed. […] Variants (also called mutations) in genes known as SNCA and SNCB can cause dementia with Lewy bodies. The SNCA and SNCB genes provide instructions for making proteins, called alpha-synuclein and beta-synuclein, respectively, that are found primarily in the brain. Alpha-synuclein plays a role in communication between nerve cells (neurons), helping to regulate the release of chemical messengers (neurotransmitters). Beta-synuclein is likely involved in a process that allows neurons to change and adapt over time, which is necessary for learning and memory. Beta-synuclein may also prevent harmful accumulation of alpha-synuclein in neurons.
  • #62 Dementia With Lewy Bodies and Parkinson Disease Dementia – Brain, Spinal Cord, and Nerve Disorders – Merck Manual Consumer Version
    https://www.merckmanuals.com/home/brain-spinal-cord-and-nerve-disorders/delirium-and-dementia/dementia-with-lewy-bodies-and-parkinson-disease-dementia
    Dementia with Lewy bodies is progressive loss of mental function characterized by the development of Lewy bodies in nerve cells. […] Dementia with Lewy bodies usually develops in people older than 60. […] In dementia with Lewy bodies and Parkinson disease dementia, abnormal round deposits of a protein (called Lewy bodies) form in nerve cells. Lewy bodies result in the death of nerve cells. […] In this disorder, synuclein (a protein in the brain that helps nerve cells communicate) changes shape (misfolds) and slowly accumulates mostly in the brain but also in the digestive tract and heart. These abnormal deposits of synuclein are called Lewy bodies. The misfolded synuclein in Lewy bodies triggers more synuclein to misfold, resulting in the formation of more Lewy bodies. Brain damage results from the accumulation of Lewy bodies.
  • #63 Lewy Body Dementia – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK482441/
    Lewy Body Dementia (LBD) encompasses two clinical entities: dementia with Lewy bodies and Parkinson disease dementia. […] The etiology of LBD is still unknown; however, genetics, environmental factors, and changes linked to aging may have a role and still require further research. […] Genetic mutations, environmental toxins, and the aging process can lead to alpha-synuclein misfolding and its accumulation in Lewy bodies via oxidative stress and mitochondrial dysfunction.
  • #64 Dementia with Lewy bodies: MedlinePlus GeneticsLock
    https://medlineplus.gov/genetics/condition/dementia-with-lewy-bodies/
    Changes in these four genes can lead to the formation of Lewy bodies, which are clusters of alpha-synuclein protein. SNCA gene variants result in misshapen alpha-synuclein proteins that cluster together (aggregate). SNCB gene variants lead to the production of an altered beta-synuclein protein that allows accumulation of alpha-synuclein. GBA1 gene variants are thought to disrupt the normal function of lysosomes. Research suggests that malfunctioning lysosomes impair the breakdown of alpha-synuclein, increasing the risk of its accumulation and the formation of Lewy bodies. […] In dementia with Lewy bodies, alpha-synuclein clusters accumulate inside and outside of neurons throughout the brain where they impair cell function and ultimately cause cell death. Neurons that produce the neurotransmitter dopamine seem to be particularly vulnerable to Lewy bodies. Dopamine has many important functions, including playing complex roles in cognition, motivation, behavior, and control of movement. Over time, the loss of dopamine-producing neurons can increasingly impair intellectual and motor function and the regulation of emotions, resulting in the signs and symptoms of dementia with Lewy bodies.
  • #65 Dementia with Lewy bodies (DLB): what is it and what causes it? | Alzheimer’s Society
    https://www.alzheimers.org.uk/about-dementia/types-dementia/dementia-with-lewy-bodies
    Dementia with Lewy bodies (DLB) is a type of dementia caused by Lewy bodies, which are clumps of protein in the cells of the brain. […] Dementia is caused by different diseases that affect the brain. Lewy body dementia is caused by Lewy body disease. […] It is not yet known why Lewy bodies develop in the brain or exactly how they cause dementia. But we do know that Lewy body disease: can cause different symptoms depending on what parts of the brain have the biggest build-up of faulty proteins, reduces the levels of important chemicals needed to send messages around the brain, breaks the connections between nerve cells, eventually causing these cells to stop working, usually develops over a period of many years typically when a person is approaching old age. Lewy bodies can be developing in the brain for a long time before any symptoms show.
  • #66 Dementia with Lewy bodies: MedlinePlus GeneticsLock
    https://medlineplus.gov/genetics/condition/dementia-with-lewy-bodies/
    Changes in these four genes can lead to the formation of Lewy bodies, which are clusters of alpha-synuclein protein. SNCA gene variants result in misshapen alpha-synuclein proteins that cluster together (aggregate). SNCB gene variants lead to the production of an altered beta-synuclein protein that allows accumulation of alpha-synuclein. GBA1 gene variants are thought to disrupt the normal function of lysosomes. Research suggests that malfunctioning lysosomes impair the breakdown of alpha-synuclein, increasing the risk of its accumulation and the formation of Lewy bodies. […] In dementia with Lewy bodies, alpha-synuclein clusters accumulate inside and outside of neurons throughout the brain where they impair cell function and ultimately cause cell death. Neurons that produce the neurotransmitter dopamine seem to be particularly vulnerable to Lewy bodies. Dopamine has many important functions, including playing complex roles in cognition, motivation, behavior, and control of movement. Over time, the loss of dopamine-producing neurons can increasingly impair intellectual and motor function and the regulation of emotions, resulting in the signs and symptoms of dementia with Lewy bodies.
  • #67 Dementia with Lewy bodies: what is it and what causes it? | Alzheimer Disease Foundation
    https://adfm.org.my/dementia-with-lewy-bodies-what-is-it-and-what-causes-it/
    Dementia with Lewy bodies (DLB) may account for 10-15 per cent of all cases of dementia. […] Researchers dont have a full understanding of why Lewy bodies appear, or exactly how they contribute to dementia. However, this is linked to two factors: low levels of important chemicals (mainly acetylcholine and dopamine) that carry messages between nerve cells and a loss of connections between nerve cells, which then die. […] Lewy bodies are the cause of DLB and Parkinsons disease. […] The way someone is affected by DLB will depend partly on where the Lewy bodies are in the brain. […] A person with Parkinsons disease is at high risk of going on to develop dementia (Parkinsons disease dementia) as their condition progresses.
  • #68 What Is Lewy Body Dementia? Types, Symptoms & Causes | Terra Vista
    https://www.terravista.org/blog/what-is-lewy-body-dementia-types-symptoms-causes/
    Lewy Body Dementia can develop when the proteins start to clump together in the brain. […] These clumps gradually affect the neurons productivity levels until the neurons die off. […] Lewy Body Dementia also impacts brain chemicals that can widely damage certain brain regions such as the cerebral cortex, limbic cortex, hippocampus, basal ganglia, brain stem, and olfactory pathways. […] Cognitive decline notably impacting everyday activities is often associated with Dementia with Lewy Bodies. […] The initial symptoms of this progressive disease differ from Parkinsons disease but worsen over time and eventually cause severe motor-related problems. […] Dementia with Lewy Bodies makes it difficult for an affected person to focus, problem-solve, and perceive things correctly. […] Lewy Body Dementia can cause vivid hallucinations related to any of the five senses.
  • #69 Lewy body dementia – Wikipedia
    https://en.wikipedia.org/wiki/Lewy_body_dementia
    Lewy body dementia (LBD) is an umbrella term for two similar and common subtypes of dementia: dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD). […] The exact cause is unknown, but involves widespread deposits of abnormal clumps of protein that form in neurons of the diseased brain. […] The fifth revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) gives Lewy body disease as the causative subtype of dementia with Lewy bodies, and Parkinson’s disease as the causative subtype of Parkinson’s disease dementia. […] Dementia with Lewy bodies and Parkinson’s disease dementia are similar in many ways, suggesting there may be a common pathophysiological mechanism, with PDD and DLB at opposite ends of a Lewy body disease spectrum, and a shared component of protein deposits in Lewy bodies and Lewy neurites.
  • #70 Lewy body dementia – Wikipedia
    https://en.wikipedia.org/wiki/Lewy_body_dementia
    DSM-5 gives Lewy body disease as the causative subtype of DLB, and Parkinson’s disease as the causative subtype of PDD. […] Despite differences in the timing of the appearance of symptoms, the two dementias „show remarkably convergent neuropathological changes at autopsy”. […] The relationship between Parkinson’s disease dementia and dementia with Lewy bodies is unclear as of 2020, but there is likely to be genetic overlap, and the two conditions may represent different points on a continuum.
  • #71 Lewy Bodies, Dementia, and Parkinson’s – What Does it all Mean? | American Parkinson Disease Association
    https://www.apdaparkinson.org/article/understanding-parkinsons-disease-dementia-lewy-bodies/
    However, because both DLB and PDD are characterized by abnormal accumulations of alpha-synuclein and loss of dopamine nerve endings, each of these biomarkers are abnormal in both PDD and DLB and current tests are not able to distinguish between the two. […] Treatments for DLB are similar to those for PDD and are aimed at symptom control. […] However, two anti-psychotic medications, quetiapine and clozapine, are sometimes used in PDD and DLB patients as they have less of an ability to worsen motor symptoms. […] Cognitive symptoms in DLB can be treated with the same medications developed for other dementias.
  • #72 What Is Lewy Body Dementia?
    https://www.alzheimers.gov/alzheimers-dementias/lewy-body-dementia
    In people with LBD, abnormal clumps of a protein called alpha-synuclein accumulate in areas of the brain involved in thinking, memory, and movement. The clumps are called „Lewy bodies” after the doctor who discovered them. They build up inside neurons, or nerve cells, in the brain and cause the neurons not to work well and eventually die. Certain chemicals in the brain that act as messengers between cells are also affected. What causes these changes in the brain is not yet fully understood. […] Most cases of LBD are not inherited and rarely does more than one family member have the disease. Certain genetic variants may increase the chance of developing dementia with Lewy bodies, but having a genetic variant does not mean that a person will definitely develop the disease. […] In dementia with Lewy bodies, problems with thinking, unpredictable changes in attention and alertness, and visual hallucinations develop early in relation to movement symptoms, such as slow movement, difficulty walking, and muscle stiffness. […] Dementia with Lewy bodies is often hard to diagnose early because symptoms may at first look like Alzheimer’s or a mental illness such as schizophrenia. LBD can also occur alongside other forms of dementia.
  • #73 What Is Lewy Body Dementia? Types, Symptoms & Causes | Terra Vista
    https://www.terravista.org/blog/what-is-lewy-body-dementia-types-symptoms-causes/
    Once a family member reaches the late stages of Lewy Body Dementia, they can be exposed to physical symptoms such as body tremors, dexterity loss, slow movement, stiffness, reduced joint flexibility, muscle twitches, loss of balance, and limited facial expressiveness. […] Rapid Eye Movement Sleep Behavior Disorder brought on by Lewy Body Dementia causes extreme drowsiness because of vivid dreaming, sleep talking, and constant tossing. […] While Dementia with Lewy Bodies initially impairs someones cognition and later their movement, a diagnosis of Parkinsons Disease is given when the opposite occurs: their physical motor skills are more prominently impacted than their mental or psychological abilities.
  • #74 Dementia with Lewy bodies (DLB): what is it and what causes it? | Alzheimer’s Society
    https://www.alzheimers.org.uk/about-dementia/types-dementia/dementia-with-lewy-bodies
    Having Lewy body disease doesn’t mean that a person’s dementia is only caused by the build-up of Lewy bodies in their brain. […] Many people with DLB also have a build-up of other proteins that cause Alzheimer’s disease. This is common in people over about 80 years old. For people with both DLB and Alzheimer’s, dementia symptoms are often more severe and progress more quickly. […] Almost all people who develop DLB have a sporadic form, which means that the main cause is unknown. Some genes may increase the risk of developing DLB.
  • #75 Dementia with Lewy bodies (DLB): what is it and what causes it? | Alzheimer’s Society
    https://www.alzheimers.org.uk/about-dementia/types-dementia/dementia-with-lewy-bodies
    Having Lewy body disease doesn’t mean that a person’s dementia is only caused by the build-up of Lewy bodies in their brain. […] Many people with DLB also have a build-up of other proteins that cause Alzheimer’s disease. This is common in people over about 80 years old. For people with both DLB and Alzheimer’s, dementia symptoms are often more severe and progress more quickly. […] Almost all people who develop DLB have a sporadic form, which means that the main cause is unknown. Some genes may increase the risk of developing DLB.
  • #76 Does dementia with Lewy bodies impact people differently based on sex? » Norman Fixel Institute for Neurological Diseases » University of Florida
    https://fixel.ufhealth.org/2023/01/30/does-dementia-with-lewy-bodies-impact-people-differently-based-on-sex/
    Parkinson-like movement changes appear more frequent in men with DLB, while frequency of fluctuations (ups and downs in alertness) appears similar between the sexes. […] Women tend to be older, have more memory and thinking changes at their first visit, and are delayed in meeting DLB diagnostic criteria compared to men. […] On autopsy, women are more likely to have mixed Lewy body disease and co-existing Alzheimer related pathology than so-called pure Lewy body disease, while men may present with either.
  • #77 Lewy Body Dementia vs. Alzheimer’s Disease
    https://www.verywellhealth.com/difference-between-alzheimers-and-lewy-body-dementia-98749
    Lewy body dementia is caused by the abnormal buildup of proteins, called Lewy bodies, in the brain. When clumps of these proteins accumulate, nerves in the brain start to lose their function and eventually die. The damage in the brain is widespread and affects many domains of thinking and functioning. […] The underlying causes of Alzheimer’s and LBD can and often do overlap. As a result, a person with LBD might experience Alzheimer-type changes in their brain, resulting in shared characteristics and symptoms referred to as mixed dementia. […] LBD is caused by abnormal deposits of proteins called Lewy bodies in the brain. These proteins are also associated with Parkinson’s disease dementia. […] Alzheimer’s is caused by the abnormal buildup of proteins called amyloid in the brain and the abnormal formation of a protein called tau that blocks nerve signals.
  • #78 What Is Lewy Body Dementia?
    https://www.alzheimers.gov/alzheimers-dementias/lewy-body-dementia
    In people with LBD, abnormal clumps of a protein called alpha-synuclein accumulate in areas of the brain involved in thinking, memory, and movement. The clumps are called „Lewy bodies” after the doctor who discovered them. They build up inside neurons, or nerve cells, in the brain and cause the neurons not to work well and eventually die. Certain chemicals in the brain that act as messengers between cells are also affected. What causes these changes in the brain is not yet fully understood. […] Most cases of LBD are not inherited and rarely does more than one family member have the disease. Certain genetic variants may increase the chance of developing dementia with Lewy bodies, but having a genetic variant does not mean that a person will definitely develop the disease. […] In dementia with Lewy bodies, problems with thinking, unpredictable changes in attention and alertness, and visual hallucinations develop early in relation to movement symptoms, such as slow movement, difficulty walking, and muscle stiffness. […] Dementia with Lewy bodies is often hard to diagnose early because symptoms may at first look like Alzheimer’s or a mental illness such as schizophrenia. LBD can also occur alongside other forms of dementia.
  • #79 Lewy Body Dementia: Causes, Symptoms, and Diagnosis | National Institute on Aging
    https://www.nia.nih.gov/health/lewy-body-dementia/lewy-body-dementia-causes-symptoms-and-diagnosis
    LBD is a disease associated with abnormal deposits of a protein called alpha-synuclein in the brain. […] The precise cause of LBD is unknown, but scientists are learning more about its biology and genetics. […] For example, they know that an accumulation of Lewy bodies is associated with a loss of certain neurons in the brain that produce important neurotransmitters, which are chemicals that act as messengers between brain cells. […] Age is considered the greatest risk factor, with most people developing the disorder over age 50. […] Other known risk factors for LBD include the following: Certain diseases and health conditions, particularly REM sleep behavior disorder and loss of smell, are linked to a higher risk of LBD. […] While having a family member with LBD may increase a person’s risk, LBD is not typically considered a hereditary disease. […] However, in most cases, the cause of LBD is unknown. […] Scientists are exploring many avenues to develop better ways to diagnose and treat LBD.
  • #80 Lewy Body Dementia: Causes, Symptoms, and Diagnosis | National Institute on Aging
    https://www.nia.nih.gov/health/lewy-body-dementia/lewy-body-dementia-causes-symptoms-and-diagnosis
    LBD is a disease associated with abnormal deposits of a protein called alpha-synuclein in the brain. […] The precise cause of LBD is unknown, but scientists are learning more about its biology and genetics. […] For example, they know that an accumulation of Lewy bodies is associated with a loss of certain neurons in the brain that produce important neurotransmitters, which are chemicals that act as messengers between brain cells. […] Age is considered the greatest risk factor, with most people developing the disorder over age 50. […] Other known risk factors for LBD include the following: Certain diseases and health conditions, particularly REM sleep behavior disorder and loss of smell, are linked to a higher risk of LBD. […] While having a family member with LBD may increase a person’s risk, LBD is not typically considered a hereditary disease. […] However, in most cases, the cause of LBD is unknown. […] Scientists are exploring many avenues to develop better ways to diagnose and treat LBD.
  • #81 Dementia with Lewy bodies: an update and outlook | Molecular Neurodegeneration | Full Text
    https://molecularneurodegeneration.biomedcentral.com/articles/10.1186/s13024-019-0306-8
    The strongest and most replicated genetic risk factors for DLB are unequivocally APOE 4 allele and Glucocerebrosidase (GBA). DLB patients are 8 times more likely to be carriers of GBA mutations than controls. […] DLB appears to be genetically heterogeneous, with a rare contribution of pathogenic causative mutations and relatively common risk factors, which may explain why DLB is a relatively common disorder, but with a reduced aggregation in families.
  • #82 What is Dementia with Lewy Bodies?
    https://nanfoundation.org/neurologic-disorders-2/dementias/what-is-dementia-with-lewy-bodies
    Dementia with Lewy Bodies (DLB) is a form of dementia associated with the presence of Lewy Bodies in the brain along with a characteristic set of symptoms and disease progression. […] Lewy Bodies are not exclusively found in the brains of individuals with DLB but have also been found in individuals with Parkinsons disease and Alzheimers disease. […] The diagnosis cannot be confirmed definitively without a post-mortem autopsy but it can be made clinically based on an individuals symptoms. […] A diagnosis of DLB is suggested when symptoms of dementia occur before or at the same time as symptoms of Parkinsonism. If motor symptoms are present prior to the onset of dementia a different diagnosis, such as Parkinsons disease dementia, is suggested. […] There is no cure for DLB. As with any dementia diagnosis, treatment primarily entails management of symptoms and increased oversight by others to ensure safety.
  • #83 Does dementia with Lewy bodies impact people differently based on sex? » Norman Fixel Institute for Neurological Diseases » University of Florida
    https://fixel.ufhealth.org/2023/01/30/does-dementia-with-lewy-bodies-impact-people-differently-based-on-sex/
    Your sex may impact the symptoms and signs of a developing brain diseases like dementia with Lewy bodies (DLB), a disease that causes memory and thinking problems along with other symptoms such as Parkinson-like movement changes, hallucinations, ups and downs in alertness, and acting out of dreams. […] Many studies show that DLB is more common in men, but this finding is inconsistent and varies by study approach. […] Women with DLB are typically under-represented in clinical trial research, said Dr. Chiu. […] Based on research with specific data on sex or gender, Drs. Chiu and Armstrong found the following conclusions: Visual hallucinations are more common and occur earlier in women with DLB, whereas Rapid Eye Movement (REM) sleep behavior disorder (acting out dreams) may be more common and occur earlier in men with DLB.
  • #84 Clinical features and diagnosis of dementia with Lewy bodies – UpToDate
    https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-dementia-with-lewy-bodies
    Dementia with Lewy bodies (DLB) is one of the most common types of degenerative dementias, second to Alzheimer disease (AD). In addition to dementia, distinctive clinical features include visual hallucinations, parkinsonism, cognitive fluctuations, rapid eye movement (REM) sleep behavior disorder (RBD), dysautonomia, and neuroleptic sensitivity. […] The pathological hallmark of DLB is the presence of eosinophilic intracytoplasmic inclusions called Lewy bodies that contain aggregated alpha-synuclein. Lewy bodies are typically present in the deep cortical layers throughout the brain, especially in anterior frontal and temporal lobes, cingulate gyrus, and insula. […] Clinical diagnostic criteria for DLB are continually being refined to improve specificity and sensitivity. Appropriate diagnosis is critical in order to provide the best treatment in regard to maximizing efficacy and limiting adverse effects.
  • #85
    https://link.springer.com/article/10.1007/s40120-018-0104-1
    Dementia with Lewy bodies is one of the most common causes of dementia. […] The disease is caused by an accumulation of alpha-synuclein protein within neurons in the brain; these protein aggregates are known as Lewy bodies. […] The incidence of DLB is strongly associated with increasing age and male gender. […] The environment has been observed to have an effect on the mortality of patients who suffer from DLB. […] Neuroleptic sensitivity is a widely recognized feature of DLB. […] This cholinergic deficiency is thought to contribute to the neuropsychiatric symptoms of DLB. […] The diagnosis of probable DLB can be made if one or more of the indicative biomarkers is associated with one or more of the aforementioned core clinical features. […] Genetics and fluid studies do not currently have any established utility in the diagnosis of DLB.
  • #86 Lewy body dementia – Dementia UK
    https://www.dementiauk.org/information-and-support/types-of-dementia/dementia-with-lewy-bodies/
    Lewy body dementia is caused by abnormal clumps of protein (called Lewy bodies) gathering inside brain cells. These Lewy bodies can build up in many parts of the brain but particularly in the areas responsible for thought, movement, visual perception and regulating sleep and alertness. […] A person with Lewy body dementia might: have recurring visual hallucinations – see things that are not there (these can be pleasant or upsetting) […] Memory is often less affected than with other types of dementia but people may be at more risk of mood and behaviour changes such as apathy, anxiety, depression, delusions and paranoia. […] It is important for someone with Lewy body dementia to get an accurate diagnosis so they get the right treatment and support. Diagnosis should include gathering information on the person’s symptoms and a specific scan called a SPECT (single photon emission computed tomography) scan may help support a diagnosis of Lewy body dementia. […] Importantly many people with Lewy body dementia are particularly sensitive to medications used to treat hallucinations and only certain types should be used with extreme caution.
  • #87 Dementia with Lewy Bodies | Penn State Health
    https://www.pennstatehealth.org/services-treatments/dementia-lewy-bodies
    Dementia with Lewy bodies (DLB) is a cognitive disorder that causes a progressive decline in your ability to think and process information. Named after the scientist who discovered them, Lewy bodies are abnormal proteins that accumulate inside your brain cells and damage the areas of your brain that affect memory, movement, behavior and mental capabilities. […] There is currently no cure for DLB. There are no known therapies that stop the progressive decline of your ability to remember, process and communicate information. […] There is no known treatment that prevents or stops the progression of DLB.